Cybin Inc. Common Stock

Stock Chart, Company Information, and Scan Results

$4.75(as of Mar 25, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Cybin Inc. Common Stock Company Information, Fundamentals, and Technical Indicators

Stock Price$4.75
Ticker SymbolHELP
ExchangeNyse Mkt
SectorHealthcare
IndustryBiotechnology
Employees50
CountyUSA
Market Cap$225.0M
EBIDTA-119.2M
10-Day Moving Average4.73
P/E Ratio-0.68
20-Day Moving Average5.70
Forward P/E Ratio0.00
50-Day Moving Average6.47
Earnings per Share-4.30
200-Day Moving Average6.82
Profit Margin-Infinity%
RSI38.14
Shares Outstanding49.9M
ATR0.51
52-Week High9.83
Volume697,856
52-Week Low4.41
Most Recent Support Level4.41
Book Value375.9M
Most Recent Resistance Level4.95
P/B Ratio0.31
Upper Keltner6.85
P/S RatioInfinity
Lower Keltner4.54
Debt-to-Equity Ratio6.85
Next Earnings DateUnknown
Cash Surplus245.5M
Next Ex-Dividend DateUnknown

Cybin Inc., doing business as Helus Pharma, a clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions. It develops CYB003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and CYB004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders. The company also develops SPL028 injectable deuterated DMT completed phase 1 clinical intramuscular and intravenous trial; SPL026 for MDD; and CYB005, a phenethylamine derivative, which in preclinical stage to treat central nervous system, as well as has a research pipeline of investigational psychedelic-based compounds. It has a strategic partnership agreement with Segal Trials to support PARADIGM, a multinational pivotal phase 3 program evaluating CYB003 for the adjunctive treatment of major depressive disorder. The company is headquartered in Toronto, Canada.

Cybin Inc. Common Stock In Our Stock Scanner

As of Mar 26, 2026
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Double BottomScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.